Arkolith/Insider Trading/ZVRA/Form 4

McFarlane Neil F.

President and CEO, DirectorZEVRA THERAPEUTICS, INC. (ZVRA) · full profile →Form 4 · filed Feb 14, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$727K
Net Open-Market Flow
-$727K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2025Sell(S)31K$8.05$246K192K
Feb 13, 2025Sell(S)61K$7.86$482K222K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-004067) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML